Wang Jinxiu, Shi Tala, Xu Lanlan, Li Yanuo, Mi Wei, Wang Chunyang, Lu Peng, Li Lingyun, Liu Ziyue, Hu Zhiyong
School of Public Health, Binzhou Medical University, Yantai, Shandong, China.
School of Basic Medicine, Binzhou Medical University, Yantai, Shandong, China.
Front Nutr. 2024 Oct 21;11:1302260. doi: 10.3389/fnut.2024.1302260. eCollection 2024.
Vitamin D deficiency has emerged as a significant concern in public health due to its potential association with various metabolic disorders. This study aimed to investigate the relationship between serum vitamin D levels and the susceptibility to hyperlipidemia among adults. Using a multi-stage sampling approach, we recruited a cohort of 2072 eligible individuals aged over 18 years. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured alongside glucolipid metabolic markers, and comprehensive demographic and physical data were collected. The cohort exhibited a hyperlipidemia prevalence of 42.18%, with 19.88% demonstrating vitamin D deficiency. Notably, 23.68% of individuals with vitamin D deficiency also presented hyperlipidemia. Statistical analysis revealed a significantly higher prevalence of hyperlipidemia among those with vitamin D deficiency compared to those with sufficient levels (23.68% vs. 17.11%, < 0.05). After adjusting for various factors including age, geographical region, exercise status, BMI, fasting glucose level, and blood pressure, lower serum 25(OH)D concentrations were found to significantly increase the risk of hyperlipidemia (Odds Ratio [OR] = 1.41; 95% CI: 1.057, 1.885; < 0.05). Further stratification of the hyperlipidemic cohort revealed that vitamin D deficiency was associated with 1.459- and 1.578-times higher risks for total cholesterol and triglyceride abnormalities, respectively, compared to those with sufficient vitamin D levels. Moreover, each 10 ng/mL decrease in serum vitamin D level corresponded to an increased risk of total cholesterol (OR = 0.82; 95% CI: 0.728, 0.974; < 0.05) and triglyceride abnormalities (OR = 0.79; 95% CI: 0.678, 0.927; < 0.05). However, there were no significant differences observed between vitamin D-sufficient and-deficient groups regarding Low-Density Lipoprotein (LDL) and High-Density Lipoprotein (HDL) abnormalities. These findings underscore the potential role of serum vitamin D deficiency as an independent risk factor contributing to the elevated prevalence of hyperlipidemia in the adult population.
维生素D缺乏因其与各种代谢紊乱的潜在关联,已成为公共卫生领域的一个重大问题。本研究旨在调查成年人血清维生素D水平与高脂血症易感性之间的关系。我们采用多阶段抽样方法,招募了2072名年龄在18岁以上的符合条件的个体。测量血清25-羟基维生素D[25(OH)D]水平以及糖脂代谢标志物,并收集全面的人口统计学和身体数据。该队列中高脂血症患病率为42.18%,19.88%的人存在维生素D缺乏。值得注意的是,维生素D缺乏的个体中有23.68%也患有高脂血症。统计分析显示,与维生素D水平充足的人相比,维生素D缺乏的人高脂血症患病率显著更高(23.68%对17.11%,<0.05)。在调整了包括年龄、地理区域、运动状况、体重指数、空腹血糖水平和血压等各种因素后,发现较低的血清25(OH)D浓度会显著增加高脂血症的风险(优势比[OR]=1.41;95%置信区间:1.057,1.885;<0.05)。对高脂血症队列的进一步分层显示,与维生素D水平充足的人相比,维生素D缺乏与总胆固醇和甘油三酯异常风险分别高1.459倍和1.578倍相关。此外,血清维生素D水平每降低10 ng/mL,总胆固醇(OR=0.82;95%置信区间:0.728,0.974;<0.05)和甘油三酯异常(OR=0.79;95%置信区间:0.678,0.927;<0.05)的风险就会增加。然而,在低密度脂蛋白(LDL)和高密度脂蛋白(HDL)异常方面,维生素D充足组和缺乏组之间未观察到显著差异。这些发现强调了血清维生素D缺乏作为导致成年人群高脂血症患病率升高的独立危险因素的潜在作用。